T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1240)	7/3/2002 6:13:59 PM
From: scaram(o)uche	Read Replies (1) of 2243

related..... It appears that NBIX, among many, has grasped the raised bar. Is that a function of timing, serendipity that SEPR got the short end of? Or did SEPR run through some FDA stop signs? Good regulatory groups make a difference. Gary Lyons doesn't say much, but if you ask him a question, he tries to give you a good answer. Maybe that's a spirit that extends throughout the organization? If a company doesn't cut corners, constructive FDA guidance can assure that trials are sound clinical experiments, with a set bar, rather than fodder for arguments/blame.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next